MTOR and colorectal carcinoma: Similarly, a study by Weng et al. suggests that the combination of EPA, epigallocatechin-3-gallate (EGCG), and proanthocyanidins significantly inhibits the mTOR signaling pathway in CRC cells, indicating that EPA may suppress cancer progression by modulating key signaling pathways50.